Global Clinical Whole Exome Sequencing (WES) Supply, Demand and Key Producers, 2023-2029
The global Clinical Whole Exome Sequencing (WES) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Clinical Whole Exome Sequencing (WES) is a comprehensive genetic test that identifies changes in a patient's DNA that cause or are related to their medical problems. By focusing on the entire protein-coding region of the genome (the exome), it provides the coverage needed to diagnose patients quickly and reliably.
This report studies the global Clinical Whole Exome Sequencing (WES) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Whole Exome Sequencing (WES), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Whole Exome Sequencing (WES) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Clinical Whole Exome Sequencing (WES) total market, 2018-2029, (USD Million)
Global Clinical Whole Exome Sequencing (WES) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Clinical Whole Exome Sequencing (WES) total market, key domestic companies and share, (USD Million)
Global Clinical Whole Exome Sequencing (WES) revenue by player and market share 2018-2023, (USD Million)
Global Clinical Whole Exome Sequencing (WES) total market by Type, CAGR, 2018-2029, (USD Million)
Global Clinical Whole Exome Sequencing (WES) total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Clinical Whole Exome Sequencing (WES) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CentoXome, Mayo Clinic Laboratories, Baylor Genetics, Blueprint Genetics, GeneDx, CD Genomics, Illumina, Thermo Fisher and Labassure, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Whole Exome Sequencing (WES) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Clinical Whole Exome Sequencing (WES) Market, By Region:
1. How big is the global Clinical Whole Exome Sequencing (WES) market?
2. What is the demand of the global Clinical Whole Exome Sequencing (WES) market?
3. What is the year over year growth of the global Clinical Whole Exome Sequencing (WES) market?
4. What is the total value of the global Clinical Whole Exome Sequencing (WES) market?
5. Who are the major players in the global Clinical Whole Exome Sequencing (WES) market?
Clinical Whole Exome Sequencing (WES) is a comprehensive genetic test that identifies changes in a patient's DNA that cause or are related to their medical problems. By focusing on the entire protein-coding region of the genome (the exome), it provides the coverage needed to diagnose patients quickly and reliably.
This report studies the global Clinical Whole Exome Sequencing (WES) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Whole Exome Sequencing (WES), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Whole Exome Sequencing (WES) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Clinical Whole Exome Sequencing (WES) total market, 2018-2029, (USD Million)
Global Clinical Whole Exome Sequencing (WES) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Clinical Whole Exome Sequencing (WES) total market, key domestic companies and share, (USD Million)
Global Clinical Whole Exome Sequencing (WES) revenue by player and market share 2018-2023, (USD Million)
Global Clinical Whole Exome Sequencing (WES) total market by Type, CAGR, 2018-2029, (USD Million)
Global Clinical Whole Exome Sequencing (WES) total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Clinical Whole Exome Sequencing (WES) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CentoXome, Mayo Clinic Laboratories, Baylor Genetics, Blueprint Genetics, GeneDx, CD Genomics, Illumina, Thermo Fisher and Labassure, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Whole Exome Sequencing (WES) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Clinical Whole Exome Sequencing (WES) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Array-Based Exome Enrichment
- Enrichment of the Exome in Solution using Biotinylated Probes
- Rare Genetic Disease
- Genetic Testing Unsuccessful
- Others
- CentoXome
- Mayo Clinic Laboratories
- Baylor Genetics
- Blueprint Genetics
- GeneDx
- CD Genomics
- Illumina
- Thermo Fisher
- Labassure
- Yale Medicine
- Genosalut
- Caris Life Sciences
- InterGenetics
- Genomics and Pathology Services (GPS)
- 3billion
- Broad Genomic
- Roche
- Novogene
- BGI Genomics
- Shanghai Jingzhou Genomics
- Shihe Gene Biotechnology
- JUNO Genomics
1. How big is the global Clinical Whole Exome Sequencing (WES) market?
2. What is the demand of the global Clinical Whole Exome Sequencing (WES) market?
3. What is the year over year growth of the global Clinical Whole Exome Sequencing (WES) market?
4. What is the total value of the global Clinical Whole Exome Sequencing (WES) market?
5. Who are the major players in the global Clinical Whole Exome Sequencing (WES) market?
1 SUPPLY SUMMARY
1.1 Clinical Whole Exome Sequencing (WES) Introduction
1.2 World Clinical Whole Exome Sequencing (WES) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Clinical Whole Exome Sequencing (WES) Total Market by Region (by Headquarter Location)
1.3.1 World Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.3 China Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.4 Europe Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.5 Japan Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.6 South Korea Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.7 ASEAN Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.8 India Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Whole Exome Sequencing (WES) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Clinical Whole Exome Sequencing (WES) Major Market Trends
2 DEMAND SUMMARY
2.1 World Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.2 World Clinical Whole Exome Sequencing (WES) Consumption Value by Region
2.2.1 World Clinical Whole Exome Sequencing (WES) Consumption Value by Region (2018-2023)
2.2.2 World Clinical Whole Exome Sequencing (WES) Consumption Value Forecast by Region (2024-2029)
2.3 United States Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.4 China Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.5 Europe Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.6 Japan Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.7 South Korea Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.8 ASEAN Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.9 India Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
3 WORLD CLINICAL WHOLE EXOME SEQUENCING (WES) COMPANIES COMPETITIVE ANALYSIS
3.1 World Clinical Whole Exome Sequencing (WES) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Clinical Whole Exome Sequencing (WES) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Clinical Whole Exome Sequencing (WES) in 2022
3.2.3 Global Concentration Ratios (CR8) for Clinical Whole Exome Sequencing (WES) in 2022
3.3 Clinical Whole Exome Sequencing (WES) Company Evaluation Quadrant
3.4 Clinical Whole Exome Sequencing (WES) Market: Overall Company Footprint Analysis
3.4.1 Clinical Whole Exome Sequencing (WES) Market: Region Footprint
3.4.2 Clinical Whole Exome Sequencing (WES) Market: Company Product Type Footprint
3.4.3 Clinical Whole Exome Sequencing (WES) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Clinical Whole Exome Sequencing (WES) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Clinical Whole Exome Sequencing (WES) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Clinical Whole Exome Sequencing (WES) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Clinical Whole Exome Sequencing (WES) Consumption Value Comparison
4.2.1 United States VS China: Clinical Whole Exome Sequencing (WES) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Clinical Whole Exome Sequencing (WES) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Clinical Whole Exome Sequencing (WES) Companies and Market Share, 2018-2023
4.3.1 United States Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023)
4.4 China Based Companies Clinical Whole Exome Sequencing (WES) Revenue and Market Share, 2018-2023
4.4.1 China Based Clinical Whole Exome Sequencing (WES) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023)
4.5 Rest of World Based Clinical Whole Exome Sequencing (WES) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Clinical Whole Exome Sequencing (WES) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Array-Based Exome Enrichment
5.2.2 Enrichment of the Exome in Solution using Biotinylated Probes
5.3 Market Segment by Type
5.3.1 World Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
5.3.2 World Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2029)
5.3.3 World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Clinical Whole Exome Sequencing (WES) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Rare Genetic Disease
6.2.2 Genetic Testing Unsuccessful
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
6.3.2 World Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2029)
6.3.3 World Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 CentoXome
7.1.1 CentoXome Details
7.1.2 CentoXome Major Business
7.1.3 CentoXome Clinical Whole Exome Sequencing (WES) Product and Services
7.1.4 CentoXome Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 CentoXome Recent Developments/Updates
7.1.6 CentoXome Competitive Strengths & Weaknesses
7.2 Mayo Clinic Laboratories
7.2.1 Mayo Clinic Laboratories Details
7.2.2 Mayo Clinic Laboratories Major Business
7.2.3 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product and Services
7.2.4 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Mayo Clinic Laboratories Recent Developments/Updates
7.2.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
7.3 Baylor Genetics
7.3.1 Baylor Genetics Details
7.3.2 Baylor Genetics Major Business
7.3.3 Baylor Genetics Clinical Whole Exome Sequencing (WES) Product and Services
7.3.4 Baylor Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Baylor Genetics Recent Developments/Updates
7.3.6 Baylor Genetics Competitive Strengths & Weaknesses
7.4 Blueprint Genetics
7.4.1 Blueprint Genetics Details
7.4.2 Blueprint Genetics Major Business
7.4.3 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product and Services
7.4.4 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Blueprint Genetics Recent Developments/Updates
7.4.6 Blueprint Genetics Competitive Strengths & Weaknesses
7.5 GeneDx
7.5.1 GeneDx Details
7.5.2 GeneDx Major Business
7.5.3 GeneDx Clinical Whole Exome Sequencing (WES) Product and Services
7.5.4 GeneDx Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 GeneDx Recent Developments/Updates
7.5.6 GeneDx Competitive Strengths & Weaknesses
7.6 CD Genomics
7.6.1 CD Genomics Details
7.6.2 CD Genomics Major Business
7.6.3 CD Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.6.4 CD Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 CD Genomics Recent Developments/Updates
7.6.6 CD Genomics Competitive Strengths & Weaknesses
7.7 Illumina
7.7.1 Illumina Details
7.7.2 Illumina Major Business
7.7.3 Illumina Clinical Whole Exome Sequencing (WES) Product and Services
7.7.4 Illumina Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Illumina Recent Developments/Updates
7.7.6 Illumina Competitive Strengths & Weaknesses
7.8 Thermo Fisher
7.8.1 Thermo Fisher Details
7.8.2 Thermo Fisher Major Business
7.8.3 Thermo Fisher Clinical Whole Exome Sequencing (WES) Product and Services
7.8.4 Thermo Fisher Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Recent Developments/Updates
7.8.6 Thermo Fisher Competitive Strengths & Weaknesses
7.9 Labassure
7.9.1 Labassure Details
7.9.2 Labassure Major Business
7.9.3 Labassure Clinical Whole Exome Sequencing (WES) Product and Services
7.9.4 Labassure Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Labassure Recent Developments/Updates
7.9.6 Labassure Competitive Strengths & Weaknesses
7.10 Yale Medicine
7.10.1 Yale Medicine Details
7.10.2 Yale Medicine Major Business
7.10.3 Yale Medicine Clinical Whole Exome Sequencing (WES) Product and Services
7.10.4 Yale Medicine Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Yale Medicine Recent Developments/Updates
7.10.6 Yale Medicine Competitive Strengths & Weaknesses
7.11 Genosalut
7.11.1 Genosalut Details
7.11.2 Genosalut Major Business
7.11.3 Genosalut Clinical Whole Exome Sequencing (WES) Product and Services
7.11.4 Genosalut Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Genosalut Recent Developments/Updates
7.11.6 Genosalut Competitive Strengths & Weaknesses
7.12 Caris Life Sciences
7.12.1 Caris Life Sciences Details
7.12.2 Caris Life Sciences Major Business
7.12.3 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product and Services
7.12.4 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Caris Life Sciences Recent Developments/Updates
7.12.6 Caris Life Sciences Competitive Strengths & Weaknesses
7.13 InterGenetics
7.13.1 InterGenetics Details
7.13.2 InterGenetics Major Business
7.13.3 InterGenetics Clinical Whole Exome Sequencing (WES) Product and Services
7.13.4 InterGenetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 InterGenetics Recent Developments/Updates
7.13.6 InterGenetics Competitive Strengths & Weaknesses
7.14 Genomics and Pathology Services (GPS)
7.14.1 Genomics and Pathology Services (GPS) Details
7.14.2 Genomics and Pathology Services (GPS) Major Business
7.14.3 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product and Services
7.14.4 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Genomics and Pathology Services (GPS) Recent Developments/Updates
7.14.6 Genomics and Pathology Services (GPS) Competitive Strengths & Weaknesses
7.15 3billion
7.15.1 3billion Details
7.15.2 3billion Major Business
7.15.3 3billion Clinical Whole Exome Sequencing (WES) Product and Services
7.15.4 3billion Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 3billion Recent Developments/Updates
7.15.6 3billion Competitive Strengths & Weaknesses
7.16 Broad Genomic
7.16.1 Broad Genomic Details
7.16.2 Broad Genomic Major Business
7.16.3 Broad Genomic Clinical Whole Exome Sequencing (WES) Product and Services
7.16.4 Broad Genomic Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Broad Genomic Recent Developments/Updates
7.16.6 Broad Genomic Competitive Strengths & Weaknesses
7.17 Roche
7.17.1 Roche Details
7.17.2 Roche Major Business
7.17.3 Roche Clinical Whole Exome Sequencing (WES) Product and Services
7.17.4 Roche Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Roche Recent Developments/Updates
7.17.6 Roche Competitive Strengths & Weaknesses
7.18 Novogene
7.18.1 Novogene Details
7.18.2 Novogene Major Business
7.18.3 Novogene Clinical Whole Exome Sequencing (WES) Product and Services
7.18.4 Novogene Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Novogene Recent Developments/Updates
7.18.6 Novogene Competitive Strengths & Weaknesses
7.19 BGI Genomics
7.19.1 BGI Genomics Details
7.19.2 BGI Genomics Major Business
7.19.3 BGI Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.19.4 BGI Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 BGI Genomics Recent Developments/Updates
7.19.6 BGI Genomics Competitive Strengths & Weaknesses
7.20 Shanghai Jingzhou Genomics
7.20.1 Shanghai Jingzhou Genomics Details
7.20.2 Shanghai Jingzhou Genomics Major Business
7.20.3 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.20.4 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Shanghai Jingzhou Genomics Recent Developments/Updates
7.20.6 Shanghai Jingzhou Genomics Competitive Strengths & Weaknesses
7.21 Shihe Gene Biotechnology
7.21.1 Shihe Gene Biotechnology Details
7.21.2 Shihe Gene Biotechnology Major Business
7.21.3 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product and Services
7.21.4 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Shihe Gene Biotechnology Recent Developments/Updates
7.21.6 Shihe Gene Biotechnology Competitive Strengths & Weaknesses
7.22 JUNO Genomics
7.22.1 JUNO Genomics Details
7.22.2 JUNO Genomics Major Business
7.22.3 JUNO Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.22.4 JUNO Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 JUNO Genomics Recent Developments/Updates
7.22.6 JUNO Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Clinical Whole Exome Sequencing (WES) Industry Chain
8.2 Clinical Whole Exome Sequencing (WES) Upstream Analysis
8.3 Clinical Whole Exome Sequencing (WES) Midstream Analysis
8.4 Clinical Whole Exome Sequencing (WES) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Clinical Whole Exome Sequencing (WES) Introduction
1.2 World Clinical Whole Exome Sequencing (WES) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Clinical Whole Exome Sequencing (WES) Total Market by Region (by Headquarter Location)
1.3.1 World Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.3 China Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.4 Europe Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.5 Japan Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.6 South Korea Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.7 ASEAN Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.3.8 India Clinical Whole Exome Sequencing (WES) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Whole Exome Sequencing (WES) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Clinical Whole Exome Sequencing (WES) Major Market Trends
2 DEMAND SUMMARY
2.1 World Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.2 World Clinical Whole Exome Sequencing (WES) Consumption Value by Region
2.2.1 World Clinical Whole Exome Sequencing (WES) Consumption Value by Region (2018-2023)
2.2.2 World Clinical Whole Exome Sequencing (WES) Consumption Value Forecast by Region (2024-2029)
2.3 United States Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.4 China Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.5 Europe Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.6 Japan Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.7 South Korea Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.8 ASEAN Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
2.9 India Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029)
3 WORLD CLINICAL WHOLE EXOME SEQUENCING (WES) COMPANIES COMPETITIVE ANALYSIS
3.1 World Clinical Whole Exome Sequencing (WES) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Clinical Whole Exome Sequencing (WES) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Clinical Whole Exome Sequencing (WES) in 2022
3.2.3 Global Concentration Ratios (CR8) for Clinical Whole Exome Sequencing (WES) in 2022
3.3 Clinical Whole Exome Sequencing (WES) Company Evaluation Quadrant
3.4 Clinical Whole Exome Sequencing (WES) Market: Overall Company Footprint Analysis
3.4.1 Clinical Whole Exome Sequencing (WES) Market: Region Footprint
3.4.2 Clinical Whole Exome Sequencing (WES) Market: Company Product Type Footprint
3.4.3 Clinical Whole Exome Sequencing (WES) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Clinical Whole Exome Sequencing (WES) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Clinical Whole Exome Sequencing (WES) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Clinical Whole Exome Sequencing (WES) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Clinical Whole Exome Sequencing (WES) Consumption Value Comparison
4.2.1 United States VS China: Clinical Whole Exome Sequencing (WES) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Clinical Whole Exome Sequencing (WES) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Clinical Whole Exome Sequencing (WES) Companies and Market Share, 2018-2023
4.3.1 United States Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023)
4.4 China Based Companies Clinical Whole Exome Sequencing (WES) Revenue and Market Share, 2018-2023
4.4.1 China Based Clinical Whole Exome Sequencing (WES) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023)
4.5 Rest of World Based Clinical Whole Exome Sequencing (WES) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Clinical Whole Exome Sequencing (WES) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Array-Based Exome Enrichment
5.2.2 Enrichment of the Exome in Solution using Biotinylated Probes
5.3 Market Segment by Type
5.3.1 World Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
5.3.2 World Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2029)
5.3.3 World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Clinical Whole Exome Sequencing (WES) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Rare Genetic Disease
6.2.2 Genetic Testing Unsuccessful
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
6.3.2 World Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2029)
6.3.3 World Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 CentoXome
7.1.1 CentoXome Details
7.1.2 CentoXome Major Business
7.1.3 CentoXome Clinical Whole Exome Sequencing (WES) Product and Services
7.1.4 CentoXome Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 CentoXome Recent Developments/Updates
7.1.6 CentoXome Competitive Strengths & Weaknesses
7.2 Mayo Clinic Laboratories
7.2.1 Mayo Clinic Laboratories Details
7.2.2 Mayo Clinic Laboratories Major Business
7.2.3 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product and Services
7.2.4 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Mayo Clinic Laboratories Recent Developments/Updates
7.2.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
7.3 Baylor Genetics
7.3.1 Baylor Genetics Details
7.3.2 Baylor Genetics Major Business
7.3.3 Baylor Genetics Clinical Whole Exome Sequencing (WES) Product and Services
7.3.4 Baylor Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Baylor Genetics Recent Developments/Updates
7.3.6 Baylor Genetics Competitive Strengths & Weaknesses
7.4 Blueprint Genetics
7.4.1 Blueprint Genetics Details
7.4.2 Blueprint Genetics Major Business
7.4.3 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product and Services
7.4.4 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Blueprint Genetics Recent Developments/Updates
7.4.6 Blueprint Genetics Competitive Strengths & Weaknesses
7.5 GeneDx
7.5.1 GeneDx Details
7.5.2 GeneDx Major Business
7.5.3 GeneDx Clinical Whole Exome Sequencing (WES) Product and Services
7.5.4 GeneDx Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 GeneDx Recent Developments/Updates
7.5.6 GeneDx Competitive Strengths & Weaknesses
7.6 CD Genomics
7.6.1 CD Genomics Details
7.6.2 CD Genomics Major Business
7.6.3 CD Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.6.4 CD Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 CD Genomics Recent Developments/Updates
7.6.6 CD Genomics Competitive Strengths & Weaknesses
7.7 Illumina
7.7.1 Illumina Details
7.7.2 Illumina Major Business
7.7.3 Illumina Clinical Whole Exome Sequencing (WES) Product and Services
7.7.4 Illumina Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Illumina Recent Developments/Updates
7.7.6 Illumina Competitive Strengths & Weaknesses
7.8 Thermo Fisher
7.8.1 Thermo Fisher Details
7.8.2 Thermo Fisher Major Business
7.8.3 Thermo Fisher Clinical Whole Exome Sequencing (WES) Product and Services
7.8.4 Thermo Fisher Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Recent Developments/Updates
7.8.6 Thermo Fisher Competitive Strengths & Weaknesses
7.9 Labassure
7.9.1 Labassure Details
7.9.2 Labassure Major Business
7.9.3 Labassure Clinical Whole Exome Sequencing (WES) Product and Services
7.9.4 Labassure Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Labassure Recent Developments/Updates
7.9.6 Labassure Competitive Strengths & Weaknesses
7.10 Yale Medicine
7.10.1 Yale Medicine Details
7.10.2 Yale Medicine Major Business
7.10.3 Yale Medicine Clinical Whole Exome Sequencing (WES) Product and Services
7.10.4 Yale Medicine Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Yale Medicine Recent Developments/Updates
7.10.6 Yale Medicine Competitive Strengths & Weaknesses
7.11 Genosalut
7.11.1 Genosalut Details
7.11.2 Genosalut Major Business
7.11.3 Genosalut Clinical Whole Exome Sequencing (WES) Product and Services
7.11.4 Genosalut Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Genosalut Recent Developments/Updates
7.11.6 Genosalut Competitive Strengths & Weaknesses
7.12 Caris Life Sciences
7.12.1 Caris Life Sciences Details
7.12.2 Caris Life Sciences Major Business
7.12.3 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product and Services
7.12.4 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Caris Life Sciences Recent Developments/Updates
7.12.6 Caris Life Sciences Competitive Strengths & Weaknesses
7.13 InterGenetics
7.13.1 InterGenetics Details
7.13.2 InterGenetics Major Business
7.13.3 InterGenetics Clinical Whole Exome Sequencing (WES) Product and Services
7.13.4 InterGenetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 InterGenetics Recent Developments/Updates
7.13.6 InterGenetics Competitive Strengths & Weaknesses
7.14 Genomics and Pathology Services (GPS)
7.14.1 Genomics and Pathology Services (GPS) Details
7.14.2 Genomics and Pathology Services (GPS) Major Business
7.14.3 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product and Services
7.14.4 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Genomics and Pathology Services (GPS) Recent Developments/Updates
7.14.6 Genomics and Pathology Services (GPS) Competitive Strengths & Weaknesses
7.15 3billion
7.15.1 3billion Details
7.15.2 3billion Major Business
7.15.3 3billion Clinical Whole Exome Sequencing (WES) Product and Services
7.15.4 3billion Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 3billion Recent Developments/Updates
7.15.6 3billion Competitive Strengths & Weaknesses
7.16 Broad Genomic
7.16.1 Broad Genomic Details
7.16.2 Broad Genomic Major Business
7.16.3 Broad Genomic Clinical Whole Exome Sequencing (WES) Product and Services
7.16.4 Broad Genomic Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Broad Genomic Recent Developments/Updates
7.16.6 Broad Genomic Competitive Strengths & Weaknesses
7.17 Roche
7.17.1 Roche Details
7.17.2 Roche Major Business
7.17.3 Roche Clinical Whole Exome Sequencing (WES) Product and Services
7.17.4 Roche Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Roche Recent Developments/Updates
7.17.6 Roche Competitive Strengths & Weaknesses
7.18 Novogene
7.18.1 Novogene Details
7.18.2 Novogene Major Business
7.18.3 Novogene Clinical Whole Exome Sequencing (WES) Product and Services
7.18.4 Novogene Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Novogene Recent Developments/Updates
7.18.6 Novogene Competitive Strengths & Weaknesses
7.19 BGI Genomics
7.19.1 BGI Genomics Details
7.19.2 BGI Genomics Major Business
7.19.3 BGI Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.19.4 BGI Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 BGI Genomics Recent Developments/Updates
7.19.6 BGI Genomics Competitive Strengths & Weaknesses
7.20 Shanghai Jingzhou Genomics
7.20.1 Shanghai Jingzhou Genomics Details
7.20.2 Shanghai Jingzhou Genomics Major Business
7.20.3 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.20.4 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Shanghai Jingzhou Genomics Recent Developments/Updates
7.20.6 Shanghai Jingzhou Genomics Competitive Strengths & Weaknesses
7.21 Shihe Gene Biotechnology
7.21.1 Shihe Gene Biotechnology Details
7.21.2 Shihe Gene Biotechnology Major Business
7.21.3 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product and Services
7.21.4 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Shihe Gene Biotechnology Recent Developments/Updates
7.21.6 Shihe Gene Biotechnology Competitive Strengths & Weaknesses
7.22 JUNO Genomics
7.22.1 JUNO Genomics Details
7.22.2 JUNO Genomics Major Business
7.22.3 JUNO Genomics Clinical Whole Exome Sequencing (WES) Product and Services
7.22.4 JUNO Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 JUNO Genomics Recent Developments/Updates
7.22.6 JUNO Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Clinical Whole Exome Sequencing (WES) Industry Chain
8.2 Clinical Whole Exome Sequencing (WES) Upstream Analysis
8.3 Clinical Whole Exome Sequencing (WES) Midstream Analysis
8.4 Clinical Whole Exome Sequencing (WES) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Clinical Whole Exome Sequencing (WES) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Clinical Whole Exome Sequencing (WES) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Clinical Whole Exome Sequencing (WES) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Clinical Whole Exome Sequencing (WES) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Clinical Whole Exome Sequencing (WES) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Clinical Whole Exome Sequencing (WES) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Clinical Whole Exome Sequencing (WES) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Clinical Whole Exome Sequencing (WES) Players in 2022
Table 12. World Clinical Whole Exome Sequencing (WES) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Clinical Whole Exome Sequencing (WES) Company Evaluation Quadrant
Table 14. Head Office of Key Clinical Whole Exome Sequencing (WES) Player
Table 15. Clinical Whole Exome Sequencing (WES) Market: Company Product Type Footprint
Table 16. Clinical Whole Exome Sequencing (WES) Market: Company Product Application Footprint
Table 17. Clinical Whole Exome Sequencing (WES) Mergers & Acquisitions Activity
Table 18. United States VS China Clinical Whole Exome Sequencing (WES) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Clinical Whole Exome Sequencing (WES) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Clinical Whole Exome Sequencing (WES) Revenue Market Share (2018-2023)
Table 23. China Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Clinical Whole Exome Sequencing (WES) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Clinical Whole Exome Sequencing (WES) Revenue Market Share (2018-2023)
Table 29. World Clinical Whole Exome Sequencing (WES) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Clinical Whole Exome Sequencing (WES) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2029) & (USD Million)
Table 35. CentoXome Basic Information, Area Served and Competitors
Table 36. CentoXome Major Business
Table 37. CentoXome Clinical Whole Exome Sequencing (WES) Product and Services
Table 38. CentoXome Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. CentoXome Recent Developments/Updates
Table 40. CentoXome Competitive Strengths & Weaknesses
Table 41. Mayo Clinic Laboratories Basic Information, Area Served and Competitors
Table 42. Mayo Clinic Laboratories Major Business
Table 43. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product and Services
Table 44. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Mayo Clinic Laboratories Recent Developments/Updates
Table 46. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 47. Baylor Genetics Basic Information, Area Served and Competitors
Table 48. Baylor Genetics Major Business
Table 49. Baylor Genetics Clinical Whole Exome Sequencing (WES) Product and Services
Table 50. Baylor Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Baylor Genetics Recent Developments/Updates
Table 52. Baylor Genetics Competitive Strengths & Weaknesses
Table 53. Blueprint Genetics Basic Information, Area Served and Competitors
Table 54. Blueprint Genetics Major Business
Table 55. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product and Services
Table 56. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Blueprint Genetics Recent Developments/Updates
Table 58. Blueprint Genetics Competitive Strengths & Weaknesses
Table 59. GeneDx Basic Information, Area Served and Competitors
Table 60. GeneDx Major Business
Table 61. GeneDx Clinical Whole Exome Sequencing (WES) Product and Services
Table 62. GeneDx Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. GeneDx Recent Developments/Updates
Table 64. GeneDx Competitive Strengths & Weaknesses
Table 65. CD Genomics Basic Information, Area Served and Competitors
Table 66. CD Genomics Major Business
Table 67. CD Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 68. CD Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CD Genomics Recent Developments/Updates
Table 70. CD Genomics Competitive Strengths & Weaknesses
Table 71. Illumina Basic Information, Area Served and Competitors
Table 72. Illumina Major Business
Table 73. Illumina Clinical Whole Exome Sequencing (WES) Product and Services
Table 74. Illumina Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Illumina Recent Developments/Updates
Table 76. Illumina Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Major Business
Table 79. Thermo Fisher Clinical Whole Exome Sequencing (WES) Product and Services
Table 80. Thermo Fisher Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Recent Developments/Updates
Table 82. Thermo Fisher Competitive Strengths & Weaknesses
Table 83. Labassure Basic Information, Area Served and Competitors
Table 84. Labassure Major Business
Table 85. Labassure Clinical Whole Exome Sequencing (WES) Product and Services
Table 86. Labassure Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Labassure Recent Developments/Updates
Table 88. Labassure Competitive Strengths & Weaknesses
Table 89. Yale Medicine Basic Information, Area Served and Competitors
Table 90. Yale Medicine Major Business
Table 91. Yale Medicine Clinical Whole Exome Sequencing (WES) Product and Services
Table 92. Yale Medicine Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Yale Medicine Recent Developments/Updates
Table 94. Yale Medicine Competitive Strengths & Weaknesses
Table 95. Genosalut Basic Information, Area Served and Competitors
Table 96. Genosalut Major Business
Table 97. Genosalut Clinical Whole Exome Sequencing (WES) Product and Services
Table 98. Genosalut Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Genosalut Recent Developments/Updates
Table 100. Genosalut Competitive Strengths & Weaknesses
Table 101. Caris Life Sciences Basic Information, Area Served and Competitors
Table 102. Caris Life Sciences Major Business
Table 103. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product and Services
Table 104. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Caris Life Sciences Recent Developments/Updates
Table 106. Caris Life Sciences Competitive Strengths & Weaknesses
Table 107. InterGenetics Basic Information, Area Served and Competitors
Table 108. InterGenetics Major Business
Table 109. InterGenetics Clinical Whole Exome Sequencing (WES) Product and Services
Table 110. InterGenetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. InterGenetics Recent Developments/Updates
Table 112. InterGenetics Competitive Strengths & Weaknesses
Table 113. Genomics and Pathology Services (GPS) Basic Information, Area Served and Competitors
Table 114. Genomics and Pathology Services (GPS) Major Business
Table 115. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product and Services
Table 116. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Genomics and Pathology Services (GPS) Recent Developments/Updates
Table 118. Genomics and Pathology Services (GPS) Competitive Strengths & Weaknesses
Table 119. 3billion Basic Information, Area Served and Competitors
Table 120. 3billion Major Business
Table 121. 3billion Clinical Whole Exome Sequencing (WES) Product and Services
Table 122. 3billion Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. 3billion Recent Developments/Updates
Table 124. 3billion Competitive Strengths & Weaknesses
Table 125. Broad Genomic Basic Information, Area Served and Competitors
Table 126. Broad Genomic Major Business
Table 127. Broad Genomic Clinical Whole Exome Sequencing (WES) Product and Services
Table 128. Broad Genomic Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Broad Genomic Recent Developments/Updates
Table 130. Broad Genomic Competitive Strengths & Weaknesses
Table 131. Roche Basic Information, Area Served and Competitors
Table 132. Roche Major Business
Table 133. Roche Clinical Whole Exome Sequencing (WES) Product and Services
Table 134. Roche Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Roche Recent Developments/Updates
Table 136. Roche Competitive Strengths & Weaknesses
Table 137. Novogene Basic Information, Area Served and Competitors
Table 138. Novogene Major Business
Table 139. Novogene Clinical Whole Exome Sequencing (WES) Product and Services
Table 140. Novogene Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Novogene Recent Developments/Updates
Table 142. Novogene Competitive Strengths & Weaknesses
Table 143. BGI Genomics Basic Information, Area Served and Competitors
Table 144. BGI Genomics Major Business
Table 145. BGI Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 146. BGI Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. BGI Genomics Recent Developments/Updates
Table 148. BGI Genomics Competitive Strengths & Weaknesses
Table 149. Shanghai Jingzhou Genomics Basic Information, Area Served and Competitors
Table 150. Shanghai Jingzhou Genomics Major Business
Table 151. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 152. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Shanghai Jingzhou Genomics Recent Developments/Updates
Table 154. Shanghai Jingzhou Genomics Competitive Strengths & Weaknesses
Table 155. Shihe Gene Biotechnology Basic Information, Area Served and Competitors
Table 156. Shihe Gene Biotechnology Major Business
Table 157. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product and Services
Table 158. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Shihe Gene Biotechnology Recent Developments/Updates
Table 160. JUNO Genomics Basic Information, Area Served and Competitors
Table 161. JUNO Genomics Major Business
Table 162. JUNO Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 163. JUNO Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 164. Global Key Players of Clinical Whole Exome Sequencing (WES) Upstream (Raw Materials)
Table 165. Clinical Whole Exome Sequencing (WES) Typical Customers
Table 1. World Clinical Whole Exome Sequencing (WES) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Clinical Whole Exome Sequencing (WES) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Clinical Whole Exome Sequencing (WES) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Clinical Whole Exome Sequencing (WES) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Clinical Whole Exome Sequencing (WES) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Clinical Whole Exome Sequencing (WES) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Clinical Whole Exome Sequencing (WES) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Clinical Whole Exome Sequencing (WES) Players in 2022
Table 12. World Clinical Whole Exome Sequencing (WES) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Clinical Whole Exome Sequencing (WES) Company Evaluation Quadrant
Table 14. Head Office of Key Clinical Whole Exome Sequencing (WES) Player
Table 15. Clinical Whole Exome Sequencing (WES) Market: Company Product Type Footprint
Table 16. Clinical Whole Exome Sequencing (WES) Market: Company Product Application Footprint
Table 17. Clinical Whole Exome Sequencing (WES) Mergers & Acquisitions Activity
Table 18. United States VS China Clinical Whole Exome Sequencing (WES) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Clinical Whole Exome Sequencing (WES) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Clinical Whole Exome Sequencing (WES) Revenue Market Share (2018-2023)
Table 23. China Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Clinical Whole Exome Sequencing (WES) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Clinical Whole Exome Sequencing (WES) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Clinical Whole Exome Sequencing (WES) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Clinical Whole Exome Sequencing (WES) Revenue Market Share (2018-2023)
Table 29. World Clinical Whole Exome Sequencing (WES) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Clinical Whole Exome Sequencing (WES) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2029) & (USD Million)
Table 35. CentoXome Basic Information, Area Served and Competitors
Table 36. CentoXome Major Business
Table 37. CentoXome Clinical Whole Exome Sequencing (WES) Product and Services
Table 38. CentoXome Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. CentoXome Recent Developments/Updates
Table 40. CentoXome Competitive Strengths & Weaknesses
Table 41. Mayo Clinic Laboratories Basic Information, Area Served and Competitors
Table 42. Mayo Clinic Laboratories Major Business
Table 43. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product and Services
Table 44. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Mayo Clinic Laboratories Recent Developments/Updates
Table 46. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 47. Baylor Genetics Basic Information, Area Served and Competitors
Table 48. Baylor Genetics Major Business
Table 49. Baylor Genetics Clinical Whole Exome Sequencing (WES) Product and Services
Table 50. Baylor Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Baylor Genetics Recent Developments/Updates
Table 52. Baylor Genetics Competitive Strengths & Weaknesses
Table 53. Blueprint Genetics Basic Information, Area Served and Competitors
Table 54. Blueprint Genetics Major Business
Table 55. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product and Services
Table 56. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Blueprint Genetics Recent Developments/Updates
Table 58. Blueprint Genetics Competitive Strengths & Weaknesses
Table 59. GeneDx Basic Information, Area Served and Competitors
Table 60. GeneDx Major Business
Table 61. GeneDx Clinical Whole Exome Sequencing (WES) Product and Services
Table 62. GeneDx Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. GeneDx Recent Developments/Updates
Table 64. GeneDx Competitive Strengths & Weaknesses
Table 65. CD Genomics Basic Information, Area Served and Competitors
Table 66. CD Genomics Major Business
Table 67. CD Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 68. CD Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CD Genomics Recent Developments/Updates
Table 70. CD Genomics Competitive Strengths & Weaknesses
Table 71. Illumina Basic Information, Area Served and Competitors
Table 72. Illumina Major Business
Table 73. Illumina Clinical Whole Exome Sequencing (WES) Product and Services
Table 74. Illumina Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Illumina Recent Developments/Updates
Table 76. Illumina Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Major Business
Table 79. Thermo Fisher Clinical Whole Exome Sequencing (WES) Product and Services
Table 80. Thermo Fisher Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Recent Developments/Updates
Table 82. Thermo Fisher Competitive Strengths & Weaknesses
Table 83. Labassure Basic Information, Area Served and Competitors
Table 84. Labassure Major Business
Table 85. Labassure Clinical Whole Exome Sequencing (WES) Product and Services
Table 86. Labassure Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Labassure Recent Developments/Updates
Table 88. Labassure Competitive Strengths & Weaknesses
Table 89. Yale Medicine Basic Information, Area Served and Competitors
Table 90. Yale Medicine Major Business
Table 91. Yale Medicine Clinical Whole Exome Sequencing (WES) Product and Services
Table 92. Yale Medicine Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Yale Medicine Recent Developments/Updates
Table 94. Yale Medicine Competitive Strengths & Weaknesses
Table 95. Genosalut Basic Information, Area Served and Competitors
Table 96. Genosalut Major Business
Table 97. Genosalut Clinical Whole Exome Sequencing (WES) Product and Services
Table 98. Genosalut Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Genosalut Recent Developments/Updates
Table 100. Genosalut Competitive Strengths & Weaknesses
Table 101. Caris Life Sciences Basic Information, Area Served and Competitors
Table 102. Caris Life Sciences Major Business
Table 103. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product and Services
Table 104. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Caris Life Sciences Recent Developments/Updates
Table 106. Caris Life Sciences Competitive Strengths & Weaknesses
Table 107. InterGenetics Basic Information, Area Served and Competitors
Table 108. InterGenetics Major Business
Table 109. InterGenetics Clinical Whole Exome Sequencing (WES) Product and Services
Table 110. InterGenetics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. InterGenetics Recent Developments/Updates
Table 112. InterGenetics Competitive Strengths & Weaknesses
Table 113. Genomics and Pathology Services (GPS) Basic Information, Area Served and Competitors
Table 114. Genomics and Pathology Services (GPS) Major Business
Table 115. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product and Services
Table 116. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Genomics and Pathology Services (GPS) Recent Developments/Updates
Table 118. Genomics and Pathology Services (GPS) Competitive Strengths & Weaknesses
Table 119. 3billion Basic Information, Area Served and Competitors
Table 120. 3billion Major Business
Table 121. 3billion Clinical Whole Exome Sequencing (WES) Product and Services
Table 122. 3billion Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. 3billion Recent Developments/Updates
Table 124. 3billion Competitive Strengths & Weaknesses
Table 125. Broad Genomic Basic Information, Area Served and Competitors
Table 126. Broad Genomic Major Business
Table 127. Broad Genomic Clinical Whole Exome Sequencing (WES) Product and Services
Table 128. Broad Genomic Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Broad Genomic Recent Developments/Updates
Table 130. Broad Genomic Competitive Strengths & Weaknesses
Table 131. Roche Basic Information, Area Served and Competitors
Table 132. Roche Major Business
Table 133. Roche Clinical Whole Exome Sequencing (WES) Product and Services
Table 134. Roche Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Roche Recent Developments/Updates
Table 136. Roche Competitive Strengths & Weaknesses
Table 137. Novogene Basic Information, Area Served and Competitors
Table 138. Novogene Major Business
Table 139. Novogene Clinical Whole Exome Sequencing (WES) Product and Services
Table 140. Novogene Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Novogene Recent Developments/Updates
Table 142. Novogene Competitive Strengths & Weaknesses
Table 143. BGI Genomics Basic Information, Area Served and Competitors
Table 144. BGI Genomics Major Business
Table 145. BGI Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 146. BGI Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. BGI Genomics Recent Developments/Updates
Table 148. BGI Genomics Competitive Strengths & Weaknesses
Table 149. Shanghai Jingzhou Genomics Basic Information, Area Served and Competitors
Table 150. Shanghai Jingzhou Genomics Major Business
Table 151. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 152. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Shanghai Jingzhou Genomics Recent Developments/Updates
Table 154. Shanghai Jingzhou Genomics Competitive Strengths & Weaknesses
Table 155. Shihe Gene Biotechnology Basic Information, Area Served and Competitors
Table 156. Shihe Gene Biotechnology Major Business
Table 157. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product and Services
Table 158. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Shihe Gene Biotechnology Recent Developments/Updates
Table 160. JUNO Genomics Basic Information, Area Served and Competitors
Table 161. JUNO Genomics Major Business
Table 162. JUNO Genomics Clinical Whole Exome Sequencing (WES) Product and Services
Table 163. JUNO Genomics Clinical Whole Exome Sequencing (WES) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 164. Global Key Players of Clinical Whole Exome Sequencing (WES) Upstream (Raw Materials)
Table 165. Clinical Whole Exome Sequencing (WES) Typical Customers
LIST OF FIGURES
Figure 1. Clinical Whole Exome Sequencing (WES) Picture
Figure 2. World Clinical Whole Exome Sequencing (WES) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Clinical Whole Exome Sequencing (WES) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 13. Clinical Whole Exome Sequencing (WES) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Clinical Whole Exome Sequencing (WES) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Clinical Whole Exome Sequencing (WES) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Clinical Whole Exome Sequencing (WES) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Clinical Whole Exome Sequencing (WES) Markets in 2022
Figure 27. United States VS China: Clinical Whole Exome Sequencing (WES) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Clinical Whole Exome Sequencing (WES) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Clinical Whole Exome Sequencing (WES) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Type in 2022
Figure 31. Array-Based Exome Enrichment
Figure 32. Enrichment of the Exome in Solution using Biotinylated Probes
Figure 33. World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Type (2018-2029)
Figure 34. World Clinical Whole Exome Sequencing (WES) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Application in 2022
Figure 36. Rare Genetic Disease
Figure 37. Genetic Testing Unsuccessful
Figure 38. Others
Figure 39. Clinical Whole Exome Sequencing (WES) Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Clinical Whole Exome Sequencing (WES) Picture
Figure 2. World Clinical Whole Exome Sequencing (WES) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Clinical Whole Exome Sequencing (WES) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Clinical Whole Exome Sequencing (WES) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Clinical Whole Exome Sequencing (WES) Revenue (2018-2029) & (USD Million)
Figure 13. Clinical Whole Exome Sequencing (WES) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Clinical Whole Exome Sequencing (WES) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Clinical Whole Exome Sequencing (WES) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Clinical Whole Exome Sequencing (WES) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Clinical Whole Exome Sequencing (WES) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Clinical Whole Exome Sequencing (WES) Markets in 2022
Figure 27. United States VS China: Clinical Whole Exome Sequencing (WES) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Clinical Whole Exome Sequencing (WES) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Clinical Whole Exome Sequencing (WES) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Type in 2022
Figure 31. Array-Based Exome Enrichment
Figure 32. Enrichment of the Exome in Solution using Biotinylated Probes
Figure 33. World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Type (2018-2029)
Figure 34. World Clinical Whole Exome Sequencing (WES) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Clinical Whole Exome Sequencing (WES) Market Size Market Share by Application in 2022
Figure 36. Rare Genetic Disease
Figure 37. Genetic Testing Unsuccessful
Figure 38. Others
Figure 39. Clinical Whole Exome Sequencing (WES) Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
